SCHEMBL24787166

SCHEMBL24787166

O=C1CNc2nc(-c3ccccc3)ncc2CN1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.47
TNKS2 Q9H2K2 1/20 0.40
TYRO3 Q06418 2/20 0.39
NTRK2 Q16620 2/20 0.39
CLK4 Q9HAZ1 2/20 0.39
DYRK1B Q9Y463 2/20 0.39
CHEK1 O14757 1/20 0.39
AURKA O14965 1/20 0.39
DAPK3 O43293 1/20 0.39
PRKD3 O94806 1/20 0.39
MAP4K4 O95819 1/20 0.39
ABL1 P00519 1/20 0.39
NTRK1 P04629 1/20 0.39
CSF1R P07333 1/20 0.39
RET P07949 1/20 0.39
MET P08581 1/20 0.39
PDGFRB P09619 1/20 0.39
PIM1 P11309 1/20 0.39
FGFR1 P11362 1/20 0.39
PDGFRA P16234 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5804166 0.79 CYP11B1 (0.42) HTR2CTYRO3NTRK2CLK4DYRK1B
SCHEMBL17318021 0.76 KDR (0.59) HTR2CTNKS2TYRO3NTRK2CLK4
SCHEMBL17396409 0.73 TYRO3 (0.35) TYRO3DYRK1BNFKB1NFKB2RELA
SCHEMBL1253734 0.67 CA12 (0.38) TNKS2ABL1KDRGSK3BMAP2K1
SCHEMBL1750073 0.67 NPC1 (0.42) HTR2CTNKS2NPC1RAB9ASMN1; SMN2
SCHEMBL14940686 0.67 HTR2C (0.39) HTR2CTNKS2NPC1RAB9ASMN1; SMN2
SCHEMBL17811730 0.67 PDE3B (0.56) TYRO3NTRK2CLK4DYRK1BCHEK1
SCHEMBL17396612 0.66 MKNK2 (0.35)
SCHEMBL17811701 0.66 CYP11B1 (0.52) TYRO3NTRK2CLK4DYRK1BCHEK1
SCHEMBL11884599 0.65 MAOA (0.41) TYRO3NTRK2CLK4DYRK1BCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022257875-A1 PYRIMIDINE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, PREPARATION METHOD THEREFOR, AND USE THEREOF 上海日馨医药科技股份有限公司 2022-12-15 WO disclosed